|
|
|
|
Preferences for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the United States: results from the Transgender Women's Internet Survey and Testing (TWIST) study
|
|
|
Presented at HIVR4P 2024, the 5th HIV Research for Prevention Conference
|
|
|
|
|
|
|